NCT01146717

Brief Summary

This study is being done to find out whether regulation of brain blood flow is altered in patents with mild cognitive impairment (those who have memory problems but otherwise healthy) when compared with healthy elderly individuals. In addition, this study will determine whether exercise training improves brain blood flow, brain structure, and brain function in patients with mild cognitive impairment (MCI). This is a research study because at present the investigators know little about brain blood flow regulation in patients with mild cognitive impairment. The investigators also know little about whether exercise training improves brain blood flow, brain structure, and brain function in patients with mild cognitive impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 17, 2010

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

February 7, 2020

Status Verified

October 1, 2016

Enrollment Period

6.5 years

First QC Date

June 16, 2010

Last Update Submit

February 5, 2020

Conditions

Keywords

Mild Cognitive ImpairmentExercise

Outcome Measures

Primary Outcomes (1)

  • Cognitive function

    A comprehensive battery of neuropsychological tests focused on memory and executive function will be used to assess effects of exercise on cognitive function.

    One year

Secondary Outcomes (2)

  • Cerebrovascular function

    One year

  • Brain tissue volume and white matter integrity

    One year

Study Arms (2)

Exercise

EXPERIMENTAL
Behavioral: Exercise

Control group

PLACEBO COMPARATOR
Behavioral: Balance training

Interventions

ExerciseBEHAVIORAL

Patients with mild cognitive impairment will undergo moderate intensity endurance exercise training for one year.

Exercise

A group of patients with mild cognitive impairment will perform flexibility and balance training for one year as a control group.

Control group

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 55-80 years old, Male or Female
  • Control Subjects: absence of cognitive complaints and normal performance in Uniform Data Set (UDS) neuropsychological tests.
  • For patients: Diagnosis of amnestic MCI (single and multiple domains) by Petersen's criteria (as modified for ADNI-GO study).
  • Stable medical condition for \> 6 months
  • Sable medications for \>2 months (use of cholinesterase inhibitors, or prior use of multivitamins is allowed)
  • Caregiver/informant available to accompany patient for scheduled visits in case the patient develops cognitive impairment that interferes with independent study participation.
  • Fluency of patient and caregiver in English
  • Ability to return to clinic for additional visits over a 12 month period.
  • ≥ 10 years of education or enough work history to exclude mental retardation.
  • Adequate visual and auditory acuity to allow neuropsychological testing.
  • Screening laboratory tests and ECG without significant abnormalities that might interfere with the study.
  • Physical ability to undergo endurance exercise training.

You may not qualify if:

  • Diagnosis of Alzheimer's Disease or other type of dementia.
  • Participant enrolled in any other investigational drug study within 2 months or longer, depending on the investigational drug half-life.
  • Modified Hachinski Score ≥ 4.
  • Subject has history in the past 2 years of epileptic seizures, or DSM-IV criteria of any major psychiatric disorders.
  • Past history or MRI evidence of brain damage including significant trauma, stroke, hydrocephalus, mental retardation or serious neurological disorder.
  • Carotid stent or sever stenosis.
  • Significant history of active alcoholism or drug abuse.
  • History of myocardial infarction within the previous year. Unstable cardiac, renal, lung, liver or other severe chronic diseases.
  • Uncontrolled hypertension (Systolic Blood Pressure (SBP) ≥160, Diastolic Blood Pressure (DBP) ≥100)or hypotension (SBP \<100 mmHg).
  • Currently diagnosed and being treated for Diabetes Mellitus (DM).
  • Obesity with Body Mass Index (BMI) ≥ 35.
  • History of familial early onset (\<55 years old) dementia
  • Pacemaker or other medical device of metal that precludes performing MRI.
  • Subjects who have been engaged in moderate intensity aerobic exercise training for \> 30 minutes, 3 times per week over the past 2 years.
  • History of a clinical diagnosis of B12 deficiency or hypothyroidism. (stable treatment for at least 3 months is allowed).
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Southwestern ADC/Institute for Exercise and Environmental Medicine

Dallas, Texas, 75231, United States

Location

Related Publications (2)

  • Pasha EP, Rutjes E, Tomoto T, Tarumi T, Stowe A, Claassen JAHR, Munro Cullum C, Zhu DC, Zhang R. Carotid Stiffness is Associated with Brain Amyloid-beta Burden in Amnestic Mild Cognitive Impairment. J Alzheimers Dis. 2020;74(3):925-935. doi: 10.3233/JAD-191073.

  • Stowe AM, Ireland SJ, Ortega SB, Chen D, Huebinger RM, Tarumi T, Harris TS, Cullum CM, Rosenberg R, Monson NL, Zhang R. Adaptive lymphocyte profiles correlate to brain Abeta burden in patients with mild cognitive impairment. J Neuroinflammation. 2017 Jul 27;14(1):149. doi: 10.1186/s12974-017-0910-x.

Related Links

MeSH Terms

Conditions

Cognitive DysfunctionMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Rong Zhang, PhD

    UTSW

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Rong Zhang, UTSW

Study Record Dates

First Submitted

June 16, 2010

First Posted

June 17, 2010

Study Start

March 1, 2010

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

February 7, 2020

Record last verified: 2016-10

Locations